Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 2/20 | 0.35 |
| ▸ | AKT2 | P31751 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13852973 | 0.87 | ALDH1A1 (0.38) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL12690849 | 0.81 | TDP1 (0.54) | TDP1AKT1AKT2MAPTKDM4E | |
| SCHEMBL13017727 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL3443345 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL8361114 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL2929456 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL13197684 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL22356719 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL21922635 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL5143671 | 0.78 | HSD17B1 (0.45) | TDP1MAPTKDM4EALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8449989-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2013-05-28 | — | — | US | disclosed |
| US-8449989-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2013-05-28 | — | — | US | disclosed |
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD (KR) | 2009-05-14 | — | — | US | disclosed |
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD (KR) | 2009-05-14 | — | — | US | disclosed |
| US-7455917-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2008-11-25 | — | — | US | disclosed |
| US-7455917-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2008-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LEF1, CYBA, AOX1 | TDP1 826/4885AKT1 4181/4885AKT2 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.